Cero Therapeutics Holdings (CERO) Cash & Equivalents (2021 - 2026)
Cero Therapeutics Holdings' Cash & Equivalents came in at $937,512 for Q2 2026, down 71.6% from $3.3 million a year earlier but up 9.3% from the prior quarter.
Powered by 
Analysis
Cero Therapeutics Holdings (CERO) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Cero Therapeutics Holdings' Cash & Equivalents was $1.66 million, down 50.0% from FY2024.
- Cash & Equivalents carries a four-year compound annual growth rate of 10.9% (FY2021 to FY2025).
- Going back by year, Cash & Equivalents was $3.33 million in FY2024 (+107.8%), $1.6 million in FY2023 (+236.5%), $475,870 in FY2022 (-56.7%) and $1.1 million in FY2021.
- The five-year range for quarterly Cash & Equivalents is $105,234 (Q2 2023) to $5.2 million (Q1 2025).
- Year-over-year, Cash & Equivalents has declined for five consecutive quarters, with an average decline of 19.1% over the last seven quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2023 (growth of 236.5%), and the weakest in Q1 2026 (a decline of 83.5%).
- Business Quant data shows CERO's Cash & Equivalents at $857,489 (Q1 2026), $1.66 million (Q4 2025) and $2.02 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Cero Therapeutics Holdings | 638,128.24 | -4.84 Mn | - | 937,512.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 937,512.00 |
| Mar 31, 2026 | 857,489.00 |
| Dec 31, 2025 | 1.66 Mn |
| Sep 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 5.20 Mn |
| Dec 31, 2024 | 3.33 Mn |
| Sep 30, 2024 | 3.38 Mn |
| Jun 30, 2024 | 3.65 Mn |
| Mar 31, 2024 | 4.59 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 119,014.00 |
| Jun 30, 2023 | 105,234.00 |
| Mar 31, 2023 | 178,093.00 |
| Dec 31, 2022 | 475,870.00 |
| Jun 30, 2022 | 553,775.00 |
| Dec 31, 2021 | 1.10 Mn |
API Access
Cero Therapeutics Holdings Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CERO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CERO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CERO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();